BLT 0.00% 2.6¢ benitec biopharma limited

Here is another article, out today, about a lesson we did learn...

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Here is another article, out today, about a lesson we did learn in a US trial, patient recruitment and retention. It's just more evidence that the US has its problems too.
    Maybe the move to Russia is management's acknowledgement of the previous problem? If we did conduct the trial in the US and experienced recruitment problems, people would be blaming management for not learning their lessons. Seems that management is on a hiding to nothing whatever they do.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.